RESUMO
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a recently characterized disease associated with somatic mutations in the UBA1 gene, which cause dysregulation of ubiquitin-mediated processes. This case describes a 71-year-old male patient with VEXAS syndrome who presented with refractory lung inflammation with a pattern similar to computed tomography hypersensitivity pneumonitis, a novel finding in VEXAS syndrome. The presented clinical case highlights the protean involvement of the lung in VEXAS syndrome and emphasizes the importance of considering interstitial lung disease in the differential diagnosis.
Assuntos
Alveolite Alérgica Extrínseca , Enzimas Ativadoras de Ubiquitina , Humanos , Masculino , Idoso , Alveolite Alérgica Extrínseca/genética , Alveolite Alérgica Extrínseca/diagnóstico , Enzimas Ativadoras de Ubiquitina/genética , Síndrome , Vacúolos , Diagnóstico Diferencial , Tomografia Computadorizada por Raios X , Doenças Genéticas Ligadas ao Cromossomo X/genética , Doenças Genéticas Ligadas ao Cromossomo X/complicações , Doenças Genéticas Ligadas ao Cromossomo X/diagnóstico , Doenças Hereditárias Autoinflamatórias/genética , Doenças Hereditárias Autoinflamatórias/diagnóstico , Doenças Hereditárias Autoinflamatórias/complicações , Mutação , Doenças Pulmonares Intersticiais/genética , Doenças Pulmonares Intersticiais/etiologia , Doenças Pulmonares Intersticiais/diagnóstico por imagem , Pulmão/diagnóstico por imagem , Pulmão/patologiaRESUMO
The Beck Depression Inventory (BDI) is one of the most widely used measures of depression. Many studies have examined the reliability and validity of the BDI. However, we found no published studies that considered the stability of the BDI over multiple administrations (i.e., more than 3 trials), such as is common in clinical trials research and during some clinical interventions. The purpose of this study is to examine the multiple test-retest reliability of the BDI in a presumably nonclinical sample. Results show a 40% decline in BDI scores over 8 weeks, a main effect that accounts for approximately 10% of the variance. We achieved a 40% decrease in self-reported symptoms of depression due to repeated measurement alone, not due to any intervention. This change likely represents measurement error with this instrument rather than any "real" change in depression. The limitations of this study, its implications for research, and its applications to clinical practice are discussed.